NCT04110860View on ClinicalTrials.gov

Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

June 20, 2018

Study Completion Date

June 30, 2018

Conditions
Tinea Versicolor
Interventions
DRUG

voriconazole gel once daily

voriconazole is incorporated into a nanoemulsion intermediate gel state then applied on the affected areas once daily

DRUG

voriconazole gel twice daily

voriconazole is incorporated into a nanoemulsion intermediate gel state then applied on the affected areas twice daily

DRUG

placebo

the same procedure as before is used to prepare the nanoemulsion intermediate gel but the active ingredient, voriconazole, is not added then applied twice daily in the same manner

Trial Locations (1)

61519

Minia University hospital, Minya

All Listed Sponsors
lead

Sara Botros

OTHER

NCT04110860 - Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel | Biotech Hunter | Biotech Hunter